Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes - Seite 2
"We have built expertise in providing holistic, integrated solutions that combine medicines, devices, technologies and services," said Pascale Witz, Executive Vice President, Sanofi, who will lead the Global Diabetes and Cardiovascular Care Business Unit in the company's new organizational structure. "The life sciences team at Google can help us improve the patient experience, outcomes and manage healthcare costs more effectively."
"We are experiencing a worldwide pandemic of diabetes, and it's very encouraging to see healthcare and technology innovators step up to the challenge of providing cutting edge tools and care advancing technologies to help people with diabetes manage their disease, 24/7," said John L. Brooks, III, President and CEO of Joslin Diabetes Center, which is a partner to the collaboration. "Technology, sensors, analytics, and digital solutions will revolutionize how blood sugars are managed, which will deliver improved quality of life, lowering the risk of complications and reducing the costs and barriers associated with diabetes care. Ultimately, I truly hope we're able to turn the Joslin Diabetes Center into a museum."
About Diabetes
Diabetes mellitus, or simply diabetes, is a chronic disease that occurs when the pancreas is no longer able to make insulin, or when the body cannot make good use of the insulin it produces.
Insulin is a hormone made by the pancreas that acts like a key to let glucose from the food we eat pass from the blood stream into the cells in the body to produce energy. All carbohydrate foods
are broken down into glucose in the blood. Insulin helps glucose get into the cells.[1]
Not being able to produce insulin or use it effectively leads to raised glucose levels in the blood (known as hyperglycemia). Over the long-term high glucose levels are associated with damage to the body and failure of various organs and tissues.[2]
The latest edition IDF Diabetes Atlas, published on World Diabetes Day, estimates that people living with diabetes will surge from 382 million to 592 million people by 2035.[3]
Lesen Sie auch
About Sanofi Diabetes
Sanofi strives to help people manage the complex challenge of diabetes by delivering innovative, integrated and personalized solutions. Driven by valuable insights that come from listening to and
engaging with people living with diabetes, the Company is forming partnerships to offer diagnostics, therapies, services, and devices including blood glucose monitoring systems. Sanofi markets
injectable, inhaled and oral medications for people with type 1 or type 2 diabetes.